bVirginia Tech Carilion School of Medicine, Roanoke, Virginia. cPanel Chair, University of Wisconsin Hospital & Clinics, Madison, Wisconsin. dUniversity of Texas Health Science Center at Houston and McGovern Medical School, Houston, Texas; American Gastroenterological Association. eNewton-Wellesley Hospital, Newton, Massachusetts. fThe University of Texas MD Anderson Cancer Center, Houston, Texas; American College of Surgeons. gH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. hMassachusetts General Hospital, Boston, Massachusetts. iMedstar Georgetown University Hospital, Washington, District of Columbia. jCleveland Clinic, Cleveland, Ohio. kDuke University Medical Center, Durham, North Carolina. lEmory University, Atlanta, Georgia. mPenn State Health, Hershey, Pennsylvania. nUniversity of Alabama at Birmingham, Birmingham, Alabama. oBeth Israel Deaconess Medical Center, Boston, Massachusetts. pSpecialty Chair, Virginia Commonwealth University Medical Center, Richmond, Virginia. The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply individual or society endorsement of the final document. Reprint requests to: publications@acr.org Palpable Abdominal Mass-Suspected Neoplasm diagnosis, although biopsy is often warranted [6,10]. CT is considered safe and effective for guiding percutaneous biopsies if the pathology can be visualized and the operator has knowledge of technical parameters, such as the need for breath holding, triangulation methods, gantry angling, and appropriate patient positioning [11-13]. There are no recent studies that specifically address the question of whether CT should be performed with or without intravenous (IV) contrast for a palpable mass.
Palpable Abdominal Mass Suspected Neoplasm. bVirginia Tech Carilion School of Medicine, Roanoke, Virginia. cPanel Chair, University of Wisconsin Hospital & Clinics, Madison, Wisconsin. dUniversity of Texas Health Science Center at Houston and McGovern Medical School, Houston, Texas; American Gastroenterological Association. eNewton-Wellesley Hospital, Newton, Massachusetts. fThe University of Texas MD Anderson Cancer Center, Houston, Texas; American College of Surgeons. gH. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. hMassachusetts General Hospital, Boston, Massachusetts. iMedstar Georgetown University Hospital, Washington, District of Columbia. jCleveland Clinic, Cleveland, Ohio. kDuke University Medical Center, Durham, North Carolina. lEmory University, Atlanta, Georgia. mPenn State Health, Hershey, Pennsylvania. nUniversity of Alabama at Birmingham, Birmingham, Alabama. oBeth Israel Deaconess Medical Center, Boston, Massachusetts. pSpecialty Chair, Virginia Commonwealth University Medical Center, Richmond, Virginia. The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply individual or society endorsement of the final document. Reprint requests to: publications@acr.org Palpable Abdominal Mass-Suspected Neoplasm diagnosis, although biopsy is often warranted [6,10]. CT is considered safe and effective for guiding percutaneous biopsies if the pathology can be visualized and the operator has knowledge of technical parameters, such as the need for breath holding, triangulation methods, gantry angling, and appropriate patient positioning [11-13]. There are no recent studies that specifically address the question of whether CT should be performed with or without intravenous (IV) contrast for a palpable mass.